3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Arterial Occlusive Diseases in 1 studies
3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tulis, DA | 1 |
| Bohl Masters, KS | 1 |
| Lipke, EA | 1 |
| Schiesser, RL | 1 |
| Evans, AJ | 1 |
| Peyton, KJ | 1 |
| Durante, W | 1 |
| West, JL | 1 |
| Schafer, AI | 1 |
1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Arterial Occlusive Diseases
| Article | Year |
|---|---|
YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function.
Topics: Angioplasty, Balloon; Animals; Arterial Occlusive Diseases; Blood Platelets; Carotid Stenosis; Cell | 2002 |